Methods of quantifying frataxin and frataxin fusion proteins

The present disclosure provides methods for determining the amount of FXN or FXN fusion protein in a sample, e.g, a tissue sample, by using mass spectrometry.

Saved in:
Bibliographic Details
Main Authors XU, Xin, WAGNER, Erik Johan, WANG, Amy Qiu, MESS, Jean-Nicholas, BETTOUN, Joan David
Format Patent
LanguageEnglish
Published 24.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure provides methods for determining the amount of FXN or FXN fusion protein in a sample, e.g, a tissue sample, by using mass spectrometry.
Bibliography:Application Number: AU20200320210